Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...

Imperial Valley agriculture drives the economy and sustains food systems far beyond the region. Yet the long-term health ...

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

The percentage of incarcerated people charged only with misdemeanors has increased significantly, worsening the situation.

Emotional support perceived through social media was statistically associated with lower anxiety among U.S. young adults, ...

A new report from the American Civil Liberties Union of Georgia found that Fulton County officials are failing to take ...

A new analysis exploring decades of strange encounters has ignited fresh debate about one of the most bizarre mysteries in ...

Should the United States buy more destroyers, or would the money be better spent developing bases, munitions, or software?

Used carefully, AI tools can aid us in developing university policy based on evidence, not anecdote or intuition.

The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel ...

Introduction Mobile health (mHealth) technologies have become increasingly popular for monitoring mental health symptoms and lifestyle behaviours, and are largely reported to be feasible and ...

The landscape of triple-negative breast cancer (TNBC) is shifting rapidly. What was once a landscape dominated by standard cytotoxic chemotherapy is now a complex map of immunotherapy, PARP inhibitors ...